These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21875683)

  • 1. Pharmacogenetics: practices and opportunities for study design and data analysis.
    Flynn AA
    Drug Discov Today; 2011 Oct; 16(19-20):862-6. PubMed ID: 21875683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed consent in the context of pharmacogenomic research: ethical considerations.
    Howard HC; Joly Y; Avard D; Laplante N; Phillips M; Tardif JC
    Pharmacogenomics J; 2011 Jun; 11(3):155-61. PubMed ID: 21445091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why, when, and how should pharmacogenetics be applied in clinical studies?: current and future approaches to study designs.
    Stingl Kirchheiner JC; Brockmöller J
    Clin Pharmacol Ther; 2011 Feb; 89(2):198-209. PubMed ID: 21209614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in drug development.
    McCarthy AD; Kennedy JL; Middleton LT
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamentals of pharmacology and applications in pharmacogenetics.
    Al-Ghoul M; Valdes R
    Clin Lab Med; 2008 Dec; 28(4):485-97. PubMed ID: 19059057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?
    Johnson MR; Tan NC; Kwan P; Brodie MJ
    Epilepsy Behav; 2011 Sep; 22(1):3-8. PubMed ID: 21420909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rating scales, scales of measurement, issues of reliability: resolving some critical issues for clinicians and researchers.
    Cicchetti D; Bronen R; Spencer S; Haut S; Berg A; Oliver P; Tyrer P
    J Nerv Ment Dis; 2006 Aug; 194(8):557-64. PubMed ID: 16909062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving models, methods, and measures: contributions of CITRM to the field of psychological trauma.
    Keane TM
    J Trauma Stress; 2009 Dec; 22(6):632-3. PubMed ID: 19960545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing clinical research studies: Part II.
    Colling J
    Urol Nurs; 2003 Dec; 23(6):449-51, 448. PubMed ID: 14725164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics in primary care: pharmacogenomics tests and beyond.
    Bartlett G; Antoun J; Zgheib NK
    Expert Rev Mol Diagn; 2012 Nov; 12(8):841-55. PubMed ID: 23249202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing economic drivers for successful clinical implementation of pharmacogenetic testing.
    Deverka PA; McLeod HL
    Clin Pharmacol Ther; 2008 Aug; 84(2):191-3. PubMed ID: 18679180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic advantage of pharmacogenomics - clinical trials with genetic information.
    Ohashi W; Mizushima H; Tanaka H
    Stud Health Technol Inform; 2008; 136():585-90. PubMed ID: 18487794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives.
    Chumnumwat S; Lu ZH; Sukasem C; Winther MD; Capule FR; Abdul Hamid AAAT; Bhandari B; Chaikledkaew U; Chanhom N; Chantarangsu S; Charoenyingwattana A; Hang TT; Hlaing TM; Htun KS; Jittikoon J; Le L; Mahasirimongkol S; Mohamed Noor DA; Shrestha J; Suwannoi L; Tragulpiankit P; Turongkaravee S; Wattanapokayakit S; Xangsayarath P; Yuliwulandari R; Zain SM; Chantratita W
    Public Health Genomics; 2019; 22(3-4):132-139. PubMed ID: 31587001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty statistical errors even you can find in biomedical research articles.
    Lang T
    Croat Med J; 2004 Aug; 45(4):361-70. PubMed ID: 15311405
    [No Abstract]   [Full Text] [Related]  

  • 17. The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence.
    Yang M; Patel DS; Tufail W; Issa AM
    Expert Rev Pharmacoecon Outcomes Res; 2013 Oct; 13(5):597-611. PubMed ID: 24138646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving training in methodology enriches the science of psychology.
    Aiken LS; West SG; Millsap RE
    Am Psychol; 2009 Jan; 64(1):discussion 51-2. PubMed ID: 19209970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pharmacogenomics research on drug development.
    Liou SY; Stringer F; Hirayama M
    Drug Metab Pharmacokinet; 2012; 27(1):2-8. PubMed ID: 22214937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in psychiatry: translating research into clinical practice.
    Malhotra AK; Zhang JP; Lencz T
    Mol Psychiatry; 2012 Jul; 17(8):760-9. PubMed ID: 22083729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.